In breast cancer, miR-149 acts as a metastasis-repressing microRNA by limiting the colony-stimulating factor-1 (CSF1)-dependent mobilization of macrophages as well as M2 macrophage polarization [23]. Here, CSF1 is linked to breast cancer.